ENGEL, a prominent player in the plastics processing industry, has acquired Trexel, the innovator behind the MuCell® microcellular foam injection molding process, for an undisclosed amount. This corporate acquisition signifies a strategic expansion for ENGEL, integrating a key technology that enhances plastics manufacturing.
Trexel is renowned for its MuCell® microcellular foam injection molding process, which transforms thermoplastics materials by replacing the traditional pack and hold phase with cell growth. This process offers significant design flexibility and cost-saving opportunities, leading to material and weight reductions of over 20% in parts. It produces lower-stress parts with enhanced dimensional stability, reduced warpage, and the elimination of sink marks, making it a valuable solution across various industries.
The acquisition is strategically significant for ENGEL, allowing it to integrate Trexel's patented MuCell® technology directly into its portfolio of injection molding solutions. This move enables ENGEL to offer comprehensive, integrated systems that capitalize on the MuCell® process’s benefits, including improved part quality, reduced material consumption, and enhanced processing efficiency. The technology also aligns with growing industry demands for sustainable manufacturing practices, as it avoids chemical foaming agents and facilitates the recycling of consumer products.
Expected synergies include the seamless integration of Trexel’s process expertise with ENGEL’s machinery, providing customers with complete, optimized production cells. This consolidation is anticipated to accelerate the global deployment of microcellular foam injection molding across critical applications such as automotive components, consumer electronics, medical parts, and packaging. The combined entity is positioned to deliver advanced, efficient, and environmentally conscious solutions to the plastics industry.